Inactive Instrument

Press Releases Stratus Media Group Inc. OTC Bulletin Board

Equities

US8631651069

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2023	Diffusion Pharmaceuticals Inc.(NasdaqCM:DFFN) dropped from NASDAQ Composite Index	CI
2023	CervoMed Completes Merger with EIP Pharma	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Diffusion Pharma : CervoMed Corporate Presentation December 2023	12-20	PU
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma	23-08-15	AQ
Diffusion Pharmaceuticals : EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies - Form 8-K	23-08-14	PU
Diffusion Pharmaceuticals : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	23-08-09	PU
Diffusion Pharmaceuticals : EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference - Form 8-K	23-08-03	PU
DIFFUSION PHARMACEUTICALS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-06-21	AQ
DIFFUSION PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-05-15	AQ
Diffusion Pharmaceuticals : EIP Pharma to Present at JMP Securities Life Sciences Conference - Form 8-K	23-05-11	PU
DIFFUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Diffusion Pharmaceuticals Inc. - DFFN	23-03-31	BU
DIFFUSION PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	23-03-30	AQ
Diffusion Pharmaceuticals : FORM OF PARENT STOCKHOLDER SUPPORT AGREEMENT - Form 8-K	23-03-30	PU
EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative Diseases	23-03-30	AQ
DIFFUSION PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-24	AQ
DIFFUSION PHARMACEUTICALS INC. : Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-02-16	AQ
DIFFUSION PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-12-30	AQ
DIFFUSION PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-12-16	AQ
DIFFUSION PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)	22-12-06	AQ
LifeSci Special Opportunities Responds to Recent Press Release Issued by Diffusion Pharmaceuticals	22-11-17	AQ
DIFFUSION PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-14	AQ
Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update	22-11-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Stratus Media Group Inc. OTC Bulletin Board

Equities

US8631651069

Press Releases

Filters